| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 26/09/2024 | 22:09 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:BLUE | bluebird bio Inc |
| 26/09/2024 | 22:01 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:BLUE | bluebird bio Inc |
| 24/09/2024 | 13:03 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLUE | bluebird bio Inc |
| 24/09/2024 | 13:00 | Business Wire | bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 | NASDAQ:BLUE | bluebird bio Inc |
| 16/09/2024 | 22:04 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:BLUE | bluebird bio Inc |
| 13/09/2024 | 22:41 | Business Wire | bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q | NASDAQ:BLUE | bluebird bio Inc |
| 13/09/2024 | 22:37 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:BLUE | bluebird bio Inc |
| 13/09/2024 | 22:28 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:BLUE | bluebird bio Inc |
| 28/08/2024 | 14:00 | Business Wire | bluebird bio Announces September Investor Events | NASDAQ:BLUE | bluebird bio Inc |
| 23/08/2024 | 22:05 | Business Wire | bluebird bio Announces Receipt of Expected Notices from Nasdaq | NASDAQ:BLUE | bluebird bio Inc |
| 14/08/2024 | 13:13 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:BLUE | bluebird bio Inc |
| 14/08/2024 | 13:00 | Business Wire | bluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance | NASDAQ:BLUE | bluebird bio Inc |
| 12/08/2024 | 14:00 | Business Wire | bluebird bio Announces Second Quarter 2024 Results Call Date | NASDAQ:BLUE | bluebird bio Inc |
| 02/08/2024 | 22:05 | Business Wire | bluebird bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:BLUE | bluebird bio Inc |
| 03/07/2024 | 22:05 | Business Wire | bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:BLUE | bluebird bio Inc |
| 13/06/2024 | 23:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:BLUE | bluebird bio Inc |
| 04/06/2024 | 22:22 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:BLUE | bluebird bio Inc |
| 29/05/2024 | 13:00 | Business Wire | bluebird bio Appoints O. James Sterling as Chief Financial Officer | NASDAQ:BLUE | bluebird bio Inc |
| 21/05/2024 | 11:45 | PR Newswire (US) | Investors in bluebird bio, Inc. Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUE | NASDAQ:BLUE | bluebird bio Inc |
| 14/05/2024 | 11:45 | PR Newswire (US) | Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm | NASDAQ:BLUE | bluebird bio Inc |
| 09/05/2024 | 13:00 | Business Wire | bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance | NASDAQ:BLUE | bluebird bio Inc |
| 07/05/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUE | NASDAQ:BLUE | bluebird bio Inc |
| 06/05/2024 | 13:05 | Business Wire | bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events | NASDAQ:BLUE | bluebird bio Inc |
| 06/05/2024 | 13:00 | Business Wire | bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy | NASDAQ:BLUE | bluebird bio Inc |
| 03/05/2024 | 11:45 | PR Newswire (US) | Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law Firm | NASDAQ:BLUE | bluebird bio Inc |
| 26/04/2024 | 22:05 | Business Wire | bluebird bio Announces Receipt of Expected Notice from Nasdaq | NASDAQ:BLUE | bluebird bio Inc |
| 26/04/2024 | 11:45 | PR Newswire (US) | BLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | NASDAQ:BLUE | bluebird bio Inc |
| 19/04/2024 | 11:45 | PR Newswire (US) | bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUE | NASDAQ:BLUE | bluebird bio Inc |
| 12/04/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More | NASDAQ:BLUE | bluebird bio Inc |
| 11/04/2024 | 14:00 | Business Wire | bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:BLUE | bluebird bio Inc |